Viewing Study NCT04220268



Ignite Creation Date: 2024-05-06 @ 2:07 PM
Last Modification Date: 2024-10-26 @ 1:25 PM
Study NCT ID: NCT04220268
Status: UNKNOWN
Last Update Posted: 2020-01-07
First Post: 2020-01-05

Brief Title: A Prospective Cohort of Pulmonary Ground Glass Nodules Patients With Family History
Sponsor: Guangdong Provincial Peoples Hospital
Organization: Guangdong Provincial Peoples Hospital

Study Overview

Official Title: Clinical Database and Biobank of Pulmonary Ground Glass Nodules Patients With Family History a Prospective Cohort Study
Status: UNKNOWN
Status Verified Date: 2020-01
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: GGN-F
Brief Summary: The aim of the present prospective cohort study GGN-F is to study the family aggregation of pulmonary ground glass nodules via the questionnaire survey and to investigate the underlying genetic mechanism via the biobank
Detailed Description: In recent years with the development of low-dose chest CT screening more and more ground glass nodules have been found Meanwhile presenting as Ground-glass nodule GGN the early-stage lung adenocarcinoma patients with lung cancer family history have been emerging increasing in recent years in East Asian

This prospective cohort study with both a cross-sectional and a longitudinal part will include patients with pulmonary ground glass nodule which were proven malignant disease

All participants will be asked to complete questionnaire to build the clinical database of GGN patients with detailed family history Furthermore blood and surgical tumor samples will be collected as a specific biobank And the blood samples of other family members of participants will be collected with their consent and knowledge

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None